Leen Liao
No. 651, Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Corrigendum to: Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis: Cancer Treatment and Research Communications 46 (2026) 101059.
Journal: Cancer treatment and research communications
Published: January 15, 2026
Personalized neoadjuvant treatment regimen selection in locally advanced rectal cancer based on regimen-specific response modeling.
Journal: NPJ digital medicine
Published: December 25, 2025
Impact of mucinous histology on the efficacy of neoadjuvant immunotherapy in localized mismatch repair-deficient colorectal cancer.
Journal: BMC cancer
Published: November 23, 2025
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.
Journal: Cancer research
Published: August 07, 2025
Discordance between radiological and pathological response to neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancer: a meta-analysis.
Journal: Frontiers in immunology
Published: August 06, 2025
Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis.
Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis.
Journal: Cancer treatment and research communications
Published: July 01, 2025
Surgical Outcomes in Metastatic Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer After Disease Control With Immune Checkpoint Inhibitors: A Retrospective Observational Study.
Journal: Diseases of the colon and rectum
Published: June 27, 2025
Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study.
Journal: NPJ precision oncology
Published: March 28, 2025
Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer.
Journal: Cancer letters
Published: March 21, 2025
RCMIX model based on pre-treatment MRI imaging predicts T-downstage in MRI-cT4 stage rectal cancer.
Journal: Cancer letters
Published: March 01, 2025
Neoadjuvant rectal-tumor regression grade combined score as surrogate endpoint for disease-free survival in locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy.
Journal: The oncologist
Published: December 02, 2024
Last Updated: 09/26/2026